Meyka AI API is live for developers.Start building.
Advertisement
Dynavax Technologies Corporation

Dynavax Technologies Corporation (DVAX) Stock Overview

Explore Dynavax Technologies Corporation’s financial performance, market position, analyst ratings, and future outlook.

DVAX●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$15.50
$0.00(0.00%)
U.S. Market opens in 54h 46m
Advertisement

Dynavax Technologies Corporation (DVAX)

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio-47.71
EPS (TTM)$-0.37
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$12.13

DVAX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dynavax Technologies Corporation (DVAX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $12.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -47.71 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
43.52%
6-Month Change
64.72%
Year-to-Date (YTD) Change
0.78%
1-Year Change
13.22%
3-Year Change
58.81%
5-Year Change
51.81%
All-Time (Max) Change
-83.51%

Contact Information

https://www.dynavax.com
510 848 5100
2100 Powell Street, EmeryVille, CA, 94608

Company Facts

4,050 Employees
IPO DateFeb 19, 2004
CountryUS

Frequently Asked Questions